Pulsenmore Ltd (PULS) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.196x

Based on the latest financial reports, Pulsenmore Ltd (PULS) has a cash flow conversion efficiency ratio of -0.196x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-14.61 Million ≈ $-39.16K USD) by net assets (ILA74.51 Million ≈ $199.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Pulsenmore Ltd for the company's overall valuation and market capitalisation.

Pulsenmore Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Pulsenmore Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pulsenmore Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pulsenmore Ltd ranked by their cash flow conversion efficiency. Explore Pulsenmore Ltd (PULS) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Morgan Sindall Group PLC LSE:MGNS	-0.017x
Key ASIC Bhd KLSE:0143	0.182x
TherapeuticsMD Inc NASDAQ:TXMD	0.051x
Wing Yip Food Holdings Group Limited American Depositary Shares NASDAQ:WYHG	0.045x
Indofarma Tbk JK:INAF	0.021x
Chien Wei Precise Technology Co Ltd TWO:8092	0.096x
Mistral Iberia Real Estate SOCIMI S.A. MC:YMIB	-0.026x
Actuate Therapeutics, Inc. Common stock NASDAQ:ACTU	-0.611x

Annual Cash Flow Conversion Efficiency for Pulsenmore Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Pulsenmore Ltd from 2019 to 2024. View PULS stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA96.89 Million ≈ $259.75K	ILA-41.46 Million ≈ $-111.16K	-0.428x	-13.94%
2023-12-31	ILA132.23 Million ≈ $354.51K	ILA-49.66 Million ≈ $-133.15K	-0.376x	-155.89%
2022-12-31	ILA187.52 Million ≈ $502.73K	ILA-27.52 Million ≈ $-73.79K	-0.147x	+13.32%
2021-12-31	ILA153.73 Million ≈ $412.16K	ILA-26.03 Million ≈ $-69.79K	-0.169x	+94.82%
2020-12-31	ILA2.89 Million ≈ $7.75K	ILA-9.46 Million ≈ $-25.36K	-3.271x	-237.46%
2019-12-31	ILA3.75 Million ≈ $10.05K	ILA-3.63 Million ≈ $-9.74K	-0.969x	--

About Pulsenmore Ltd

TA:PULS Israel Medical Devices

Market Cap

$22.89 Million

ILA8.54 Billion ILA

Market Cap Rank

#24769 Global

#352 in Israel

Share Price

ILA1313.00

Change (1 day)

-0.15%

52-Week Range

ILA251.00 - ILA2097.00

All Time High

ILA2097.00